- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04367272
Is Second Knee at Risk During Simultaneous Bilateral Total Knee Arthroplasty.
April 29, 2020 updated by: Orkhan Aliyev, Bezmialem Vakif University
The effects of single-team simultaneous bilateral total knee arthroplasty on peri- and postoperative complications are clear.
The investigators hypothesized that second knee at risk during single-team simultaneous bilateral total knee arthroplasty and have more early postoperative complication rates than the first knee.
Therefore, this prospective study compared minor and major local complications for 90 days postoperatively between the first and second during knee single-team simultaneous bilateral total knee arthroplasty.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
The investigators would like to compare operation related technical complications and periprosthetic joint infection rate between the first and second knee.
Study Type
Interventional
Enrollment (Anticipated)
163
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary bilateral knee osteoarthritis with refractory to conservative treatment
- Patients who accept participation in the research and the randomization
Exclusion Criteria:
- no history of malignancy
- less than 75 years old
- severe cardiac insufficiency and morbid obesity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: First Knee
The first knee is the knee where the surgery will begin to be applied.
|
First Knee
|
Experimental: Second Knee
The second knee is the knee where the surgeon will apply secondly.
|
Second Knee
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Local complications
Time Frame: 90 days
|
Local operation related complications rate
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 15, 2020
Primary Completion (Anticipated)
May 15, 2021
Study Completion (Anticipated)
June 30, 2021
Study Registration Dates
First Submitted
April 25, 2020
First Submitted That Met QC Criteria
April 28, 2020
First Posted (Actual)
April 29, 2020
Study Record Updates
Last Update Posted (Actual)
April 30, 2020
Last Update Submitted That Met QC Criteria
April 29, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 27.04.2020-02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on First Arthroplasty
-
Stryker Trauma GmbHCompletedOsteoarthritis | Rheumatoid Arthritis | Bunion | Hallux Limitus of Left Great Toe | Arthritis of 1st Metatarsophalangeal Joint | Hallux Limitus of Right Great ToeItaly
-
Shandong UniversityUnknownOptical Enhancement EndoscopyChina
-
Intermountain Health Care, Inc.CompletedCardiovascular DiseaseUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
The University of Hong KongQueen Mary Hospital, Hong Kong; Ruttonjee Hospital, Hong KongCompletedAcute Ischaemic StrokeHong Kong
-
Medtronic Bakken Research CenterCompleted
-
Ottawa Hospital Research InstituteRecruiting
-
University Hospital BratislavaUnknown
-
NYU Langone HealthCompleted
-
West China HospitalUnknownLung Cancer | Surgery | Circulating Tumor CellChina